About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Massachusetts | 382 Studies

Clinical Trials Pancreatic CancerMassachusetts

Pancreatic Cancer Clinical Trials in Massachusetts

Find 382 clinical trials for pancreatic cancer near Massachusetts. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 382 trials

CompletedSafety, Pharmacokinetics and Pharmacodynamics of BEZ235 Plus MEK162 in Selected Advanced Solid Tumor PatientsThis is an open label, dose finding, phase Ib clinical trial to determine the maximum tolerated dose (MTD) and/or RP2D of the orally administered PI3K/mTOR inhibitor BEZ235 in…NCT01337765·Boston, Massachusetts and 5 others CompletedQUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasAMG 479 is an investigational fully human monoclonal antibody that targets type 1 insulin-like growth factor receptor (IGF-1R).NCT01231347·Fullerton, California and 151 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingDose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid TumorsThe purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of escalating doses of RMC-6291 (KRAS G12C(ON) inhibitor) monotherapy in adult…NCT05462717·Springdale, Arkansas and 63 others

RecruitingPancreatic Cancer Screening for At-risk IndividualsThe investigators' goal is to conduct a prospective multicenter study to evaluate the yield and outcomes of screening of pancreas cancer in individuals who are at-risk for…NCT05006131·Boston, Massachusetts

SuspendedSwitch Maintenance in PancreaticThis study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic cancer that has spread to other…NCT05419479·Boston, Massachusetts

CompletedVaccine Study for Surgically Resected Pancreatic CancerTo assess the response for subjects with pancreatic cancer that have undergone surgical resection and treatment with a vaccine given with chemotherapy and chemoradiation.NCT00569387·Scottsdale, Arizona and 17 others

UnknownA Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsThis is a phase 1, Open-label, multicenter Dose Escalation study of BTP-114, a novel platinum product, in patients with advanced solid tumors and BRCA or other DNA repair mutation.NCT02950064·Sarasota, Florida and 7 others

CompletedEnoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing MicroparticlesResearch studies have shown a strong association between cancer and blood clots in the veins (also known as deep vein thrombosis).NCT00908960·Los Angeles, California and 4 others

CompletedHydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic CancerHydroxychloroquine is approved for the treatment of non-cancerous illnesses such as rheumatoid arthritis and systemic lupus erythematous.NCT01273805·Boston, Massachusetts and 1 other

UnknownSafety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic CancerThe purpose of this clinical trial is to study an experimental drug called pembrolizumab or MK-3475 for use in combination with chemotherapy and radiation therapy for patients…NCT02305186·Phoenix, Arizona and 5 others

CompletedSafety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to ChemotherapyThe purpose of this study was to assess the efficacy and safety of everolimus in the treatment of advanced pancreatic neuroendocrine tumor (NET) not responsive to cytotoxic…NCT00363051·Birmingham, Alabama and 53 others

CompletedSafety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor CancerA multi-center Phase 1b/2 study testing the combination of AMG 820 and pembrolizumab in subjects with select advanced solid tumors.NCT02713529·Atlanta, Georgia and 14 others

Terminated89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsA prospective, open-label, phase 2 study to explore CAIX expression through 89Zirconium-labelled girentuximab deferoxamine (89Zr-girentuximab) PET/CT imaging in patients with…NCT05563272·Los Angeles, California and 9 others

RecruitingA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic CancerThis is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer.NCT07227168·San Diego, California and 8 others

CompletedGemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00026338·Tucson, Arizona and 172 others

TerminatedStudy to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid TumorsThe goal of this interventional clinical trial is to learn about TNG348, a ubiquitin specific peptidase 1 (USP1) inhibitor, alone and in combination with olaparib in patients with…NCT06065059·Denver, Colorado and 6 others

CompletedSorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsThe purpose of this research study is to find out more about the combination of RAD001 and sorafenib such as the safest dose to use, the side effects it may cause, and if the drug…NCT00942682·Boston, Massachusetts

CompletedStudy of Ruxolitinib in Pancreatic Cancer PatientsThe purpose of this study was to determine whether ruxolitinib added to capecitabine is effective in improving the overall survival of patients with metastatic pancreatic cancer.NCT01423604·Birmingham, Alabama and 38 others

CompletedA Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine TreatmentThe purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for cancer therapy, namely 5…NCT04083235·Birmingham, Alabama and 199 others

RecruitingA Study of LY4337713 in Participants With FAP-Positive Solid TumorsThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread.NCT07213791·Newport Beach, California and 29 others

PreviousPage 7 of 20Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia